10% Off
Humaglobin250 mg/5 m
City Overseas Ltd.
৳16650.00
Add to cart
Generic medicine
Human Immunoglobulin-G [IgG]: Brands, Price & Uses in Bangladesh
Human Immunoglobulin-G [IgG] is a pooled human plasma-derived immunoglobulin G preparation used for antibody replacement and immunomodulation.
About Human Immunoglobulin-G [IgG]
Indications of Human Immunoglobulin-G [IgG]
Human Immunoglobulin-G [IgG] is a pooled human plasma-derived immunoglobulin G preparation used for antibody replacement and immunomodulation. Indications vary in strength of evidence:
Established / Approved Uses
- Primary immunodeficiency (PI): Replacement therapy in primary humoral immunodeficiency disorders (e.g., common variable immunodeficiency, X-linked agammaglobulinemia) in adults and children.
- Secondary immunodeficiency: Hypogammaglobulinemia and recurrent bacterial infection associated with chronic lymphocytic leukemia (CLL) or after hematopoietic stem cell transplant.
- Idiopathic thrombocytopenic purpura (ITP): To raise platelet counts rapidly, particularly before surgery or when bleeding risk is significant.
- Kawasaki disease: Used with aspirin to reduce the risk of coronary artery abnormalities.
- Guillain-Barré syndrome (GBS): To hasten neurological recovery in acute severe disease.
- Chronic inflammatory demyelinating polyneuropathy (CIDP): Maintenance therapy to improve neuromuscular function.
- Multifocal motor neuropathy (MMN): Maintenance therapy to improve muscle strength.
Adjunct / Combination Uses
- Kawasaki disease treatment requires concurrent aspirin therapy — Human Immunoglobulin-G [IgG] alone is not considered adequate.
- Used as an adjunct with corticosteroids or other immunosuppressants in some autoimmune conditions per specialist guidance.
Off-Label Uses (specialist-directed only)
- Certain autoimmune and inflammatory neurological conditions (e.g., myasthenia gravis exacerbation, some autoimmune encephalitides) where guideline or expert-society support exists but formal approval may vary by product and country.
The exact approved indication list can differ between individual Human Immunoglobulin-G [IgG] brands/products; use only as directed by a qualified physician for a confirmed indication.
Dosage & Administration of Human Immunoglobulin-G [IgG]
Dosing of Human Immunoglobulin-G [IgG] is highly individualized by indication, product concentration, and patient body weight, and must be prescribed and supervised by a physician experienced in its use, typically administered in a hospital or infusion center with monitoring.
| Indication | Typical Adult Dosing |
|---|---|
| Primary immunodeficiency | Usually 300–600 mg/kg IV every 3–4 weeks, individualized to maintain adequate trough IgG levels; subcutaneous formulations may be dosed weekly at adjusted doses. |
| Secondary immunodeficiency (e.g., CLL) | Typically 400–600 mg/kg every 3–4 weeks. |
| Idiopathic thrombocytopenic purpura (ITP) | Commonly 1 g/kg/day IV for 1–2 days, or 400 mg/kg/day for 5 days, per treating physician. |
| Kawasaki disease | Single dose of 2 g/kg IV given over 10–12 hours, together with concurrent aspirin therapy. |
| Guillain-Barré syndrome | Total of 2 g/kg IV divided over 2–5 days. |
| CIDP (maintenance) | Initial 2 g/kg over 2–4 days, then maintenance doses (e.g., 1 g/kg every 3 weeks) individualized to response. |
Infusion rate is critical: Human Immunoglobulin-G [IgG] must be started at a slow rate and increased gradually only if well tolerated, since rapid infusion increases the risk of thrombotic, renal, and infusion-related reactions. Adequate hydration before infusion, especially in patients with renal risk factors, is recommended. Exact dose, concentration, and infusion rate depend on the specific brand of Human Immunoglobulin-G [IgG] being used — always follow the product-specific prescribing information and physician instructions.
Side Effects of Human Immunoglobulin-G [IgG]
Adverse effects of Human Immunoglobulin-G [IgG] range from common, mild infusion-related reactions to rare but serious systemic events.
Common
- Headache, chills, fever, flushing
- Fatigue, malaise
- Nausea, vomiting
- Myalgia, back pain, arthralgia
- Mild hypotension or hypertension during infusion
Serious (uncommon to rare)
- Thrombosis (arterial and venous, including myocardial infarction, stroke, deep vein thrombosis, pulmonary embolism) — a class-wide boxed-warning-level risk.
- Renal dysfunction/acute renal failure, particularly in patients with pre-existing renal impairment, diabetes, volume depletion, or those receiving sucrose-containing formulations.
- Hemolysis (immune-mediated destruction of red blood cells), occasionally severe.
- Aseptic meningitis syndrome (headache, neck stiffness, photophobia, usually resolving within days).
- Anaphylaxis and severe hypersensitivity reactions.
- Transfusion-related acute lung injury (TRALI) — noncardiogenic pulmonary edema.
- Rarely, thrombotic microangiopathy or transmission of infectious agents (minimized by donor screening and viral inactivation steps, but not entirely eliminable).
Report any severe or persistent reaction to a physician immediately, especially during or shortly after infusion.
Contraindications of Human Immunoglobulin-G [IgG]
Human Immunoglobulin-G [IgG] is contraindicated in:
- Patients with a history of anaphylactic or severe systemic hypersensitivity reaction to human immunoglobulin products or to any component of the specific Human Immunoglobulin-G [IgG] formulation being used.
- Patients with selective IgA deficiency who have known antibodies against IgA, due to the risk of severe anaphylactic reactions, particularly with products containing higher amounts of IgA.
Frequently Asked Questions about Human Immunoglobulin-G [IgG]
What is Human Immunoglobulin-G [IgG] used for?
Human Immunoglobulin-G [IgG] is used to replace missing antibodies in people with primary or secondary immunodeficiency, and to modulate the immune system in certain autoimmune and inflammatory conditions such as ITP, Kawasaki disease, Guillain-Barré syndrome, and CIDP. Your physician will confirm whether it is appropriate for your specific condition.
How is Human Immunoglobulin-G [IgG] given?
Human Immunoglobulin-G [IgG] is given by a healthcare professional, most often as a slow intravenous (IV) infusion in a hospital or infusion clinic; some formulations may be given subcutaneously for long-term immunodeficiency treatment. It is never self-administered without proper training and physician supervision.
What are the main risks of Human Immunoglobulin-G [IgG]?
The most serious risks associated with Human Immunoglobulin-G [IgG] are blood clots (thrombosis), kidney problems (including acute kidney failure), and, rarely, destruction of red blood cells (hemolysis). Your medical team will monitor you closely, especially if you have risk factors such as kidney disease, heart disease, or reduced mobility.
Can Human Immunoglobulin-G [IgG] be used during pregnancy or breastfeeding?
Human Immunoglobulin-G [IgG] should be used during pregnancy only if clearly needed and if the physician determines the benefit outweighs any potential risk to the baby. It is generally considered usable during breastfeeding when medically indicated, but you should always consult your physician before use in either situation.
Who should not receive Human Immunoglobulin-G [IgG]?
Human Immunoglobulin-G [IgG] should not be given to anyone with a known history of severe allergic (anaphylactic) reaction to human immunoglobulin products, or to people with selective IgA deficiency who have antibodies against IgA, due to the risk of severe allergic reactions.
What should I tell my doctor before receiving Human Immunoglobulin-G [IgG]?
Tell your doctor about any kidney disease, heart or blood vessel disease, diabetes, recent immobility, allergies, recent or planned vaccinations, and any other medicines you take before receiving Human Immunoglobulin-G [IgG], so the infusion rate and dose can be planned safely.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.